Risk Factors Associated with Different Stages of Atherosclerosis in Colombian Patients with Rheumatoid Arthritis

Seminars in Arthritis and Rheumatism

Volumn 38, Issue 2, 2008, Pages 71-82

  Rojas Villarraga, Adriana ^a   Ortega Hernandez, Oscar Danilo ^a   Gomez, Luis F ^b   Pardo, Aryce L ^a   López Guzmán, Silvia ^a   Arango Ferreira, Camila ^c   Hincapie, Maria Eugenia ^a   Betancur, Juan F ^c   Pineda Tamayo, Ricardo ^a   Diaz, Francisco J ^d   Anaya, Juan Manuel ^a  

^a Corporación para Investigaciones Biológicas ^*  (Colombia)

^b Clinica Medellin   (Colombia)

^c UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

^d UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

anti CCP antibodies; atherosclerotic plaque; cardiovascular disease; endothelial dysfunction; extra articular manifestations; HLA; intima media thickness; rheumatoid arthritis; rheumatoid factor; TNF

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DR ANTIGEN; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; ARTHRITIS, RHEUMATOID; CAROTID ARTERY DISEASES; COLOMBIA; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA;

EID: 52149121712     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2008.01.019     Document Type: Article

References (116)

1. Naz S.M., and Symmons D.P. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheum 21 (2007) 871-883
2. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manson J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107 (2003) 1303-1307
3. Meune C., Wahbi K., Assous N., Weber S., Kahan A., and Allanore Y. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-doppler echocardiography study. J Rheumatol 34 (2007) 2005-2009
4. La Montagna G., Cacciapuoti F., Buono R., Manzella D., Mennillo G.A., Arciello A., et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vasc Dis Res 4 (2007) 130-135
5. Chung C.P., Oeser A., Solus J.F., Avalos I., Gebretsadik T., Shintani A., et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) [Epub ahead of print]
6. Gonzalez A., Maradit Kremers H., Crowson C.S., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-RA patients?. Ann Rheum Dis (2007) [Epub ahead of print]
7. Jacobsson L.T., Turesson C., Hanson R.L., Pillemer S., Sievers M.L., Pettitt D.J., et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 44 (2001) 1170-1176
8. Glennås A., Kvien T.K., Andrup O., Karstensen B., and Munthe E. Recent onset arthritis in the elderly: a 5 year longitudinal observational study. J Rheumatol 27 (2000) 101-108
9. Lourida E.S., Georgiadis A.N., Papavasiliou E.C., Papathanasiou A.I., Drosos A.A., and Tselepis A.D. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. Arthritis Res Ther 9 (2007) R19
10. Turesson C., McClelland R.L., Christianson T.J., and Matteson E.L. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 66 (2007) 70-75
11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
12. Shoenfeld Y., Sherer Y., and Harats D. Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 22 (2001) 293-295
13. Van Doornum S., McColl G., and Wicks I.P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis Rheum 46 (2002) 862-873
14. Lim T.K., Lim E., Dwivedi G., Kooner J., Senior R., et al. Normal value of carotid intima-media thickness- a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr (2007) [Epub ahead of print]
15. Park Y.B., Ahn C.W., Choi H.K., Lee S.H., In B.H., Lee H.C., et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 46 (2002) 1714-1719
16. Kumeda Y., Inaba M., Goto H., Nagata M., Henmi Y., Furumitsu Y., et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46 (2002) 1489-1497
17. Roman M.J., Moeller E., Davis A., Paget S.A., Crow M.K., Lockshin M.D., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 144 (2006) 249-256
18. Gonzalez-Juanatey C., Llorca J., Testa A., Revuelta J., Garcia-Porrua C., and Gonzalez-Gay M.A. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 82 (2003) 407-413
19. Vaudo G., Marchesi S., Gerli R., Allegrucci R., Giordano A., Siepi D., et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Intern Med 63 (2004) 31-35
20. Dessein P.H., Joffe B.I., and Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7 (2005) R634-R643
21. Anderson T.J., Uehata A., Gerhard M.D., Meredith I.T., Knab S., Delagrange D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 (1995) 1235-1241
22. Van Doornum S., McColl G., Jenkins A., Green D.J., and Wicks I.P. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 48 (2003) 72-80
23. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins M.T., Menzoian J.O., and Vita J.A. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105 (2002) 1567-1572
24. Sherer Y., and Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2 (2006) 99-106
25. Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112 (2005) 3337-3347
26. Gonzalez-Gay M.A., Gonzalez-Juanatey C., and Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35 (2005) 8-17
27. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 (1987) 1205-1213
28. Gonzalez-Gay M.A., Gonzalez-Juanatey C., and Ollier W.E. Endothelial dysfunction in rheumatoid arthritis: Influence of HLA-DRB1 alleles. Autoimmun Rev 3 (2004) 301-304
29. Gonzalez-Juanatey C., Testa A., Garcia-Castelo A., Garcia-Porrua C., Llorca J., Vidan J., et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114 (2003) 647-652
30. Gonzalez-Gay M.A., Garcia-Porrua C., and Hajeer A.H. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31 (2002) 355-360
31. Lee Y.H., Ji J.D., and Song G.G. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 1 (2007) 43-49
32. Hajeer A.H., Dababneh A., Makki R.F., Thomson W., Poulton K., Gonzalez-Gay M.A., et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55 (2000) 319-325
33. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
34. Hürlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106 (2002) 2184-2187
35. Gonzalez-Gay M.A., De Matias J.M., Gonzalez-Juanatey C., Garcia-Porrua C., Sanchez-Andrade A., Martin J., et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24 (2006) 83-86
36. Nakamura M., Yoshida H., Arakawa N., Saitoh S., Satoh M., and Hiramori K. Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 36 (2000) 487-492
37. Jaraquemada D., Ollier W., Awad J., Young A., and Festenstein H. HLA and rheumatoid arthritis: susceptibility or severity?. Dis Markers 4 (1986) 43-53
38. Yeap S.S., Mohd A., Kumar G., Kong K.F., Chow S.K., Goh E.M., et al. The association between HLA genes and radiological erosions in Malaysian patients with rheumatoid arthritis. Autoimmunity 40 (2007) 187-190
39. Zonana M.F., Reyes E., and Weisman A.K. Coexistence of four autoimmune diseases in one patient: the kaleidoscope of autoimmunity. J Clin Rheumatol 8 (2002) 322-325
40. Lorber M., Gershwin M.E., and Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arthritis Rheum 24 (1994) 105-113
41. Anaya J.M., Corena R., Castiblanco J., Rojas-Villarraga A., and Shoenfeld Y. The kaleidoscope of autoimmunity. multiple autoimmune syndromes and familial autoimmunity. Exp Rev Clin Immunol 3 (2007) 623-635
42. Anaya J.M., Gómez L., and Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 13 (2006) 185-195
43. Dessein P.H., Norton G.R., Woodiwiss A.J., Joffe B.I., and Wolfe F. Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 34 (2007) 943-945
44. Dessein P.H., Stanwix A.E., and Moomal Z. Rheumatoid arthritis and cardiovascular disease may share similar risk factors. Rheumatology (Oxford) 40 (2001) 703-704
45. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 3 (1988) 315-324
46. Anaya J.M., Tobon G.J., Vega P., and Castiblanco J. Autoimmune disease aggregation in families with primary Sjögren's syndrome. J Rheumatol 33 (2006) 2227-2234
47. Prevoo M.L., van′t Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., and van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995) 44-48
48. Bruce B., and Fries J.F. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30 (2003) 167-178
49. van Riel P.L., and van Gestel A.M. Clinical outcome measures in rheumatoid arthritis. Ann Rheum Dis 59 Suppl 1 (2000) i28-i31
50. Correa P.A., Tobón G.J., Citera G., Cadena J., Schneeberger E., Camargo J.F., et al. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 24 (2004) 140-152
51. Correa P.A., Gomez L.M., Cadena J., and Anaya J.M. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32 (2005) 219-224
52. Anaya J.M., Correa P.A., Mantilla R.D., and Arcos-Burgos M. Rheumatoid arthritis association in Colombian population is restricted to HLA-DRB1*04 QRRAA alleles. Genes Immun 3 (2002) 56-58
53. Waldron-Lynch F., Adams C., Amos C., Zhu D.K., McDermott M.F., Shanahan F., et al. Major differences in antigen-processing correlate with a single Arg71 ↔ Lys substitution in HLA-DR molecules predisposing to rheumatoid arthritis and with their selective interactions with 70-kDa heat shock protein chaperones. J Immunol 169 (2002) 3015-3020
54. Zanelli E., Gonzalez-Gay M.A., and David C.S. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?. Immunol Today 16 (1995) 274-278
55. Mattey D.L., Dawes P.T., Gonzalez-Gay M.A., Garcia-Porrua C., Thomson W., Hajeer A.H., et al. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol 28 (2001) 232-239
56. Khani-Hanjani A., Lacaille D., Horne C., Chalmers A., Hoar D.I., Balshaw R., et al. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis. J Rheumatol 29 (2002) 1358-1365
57. van der Helm-van Mil A.H., Huizinga T.W., Schreuder G.M., Breedveld F.C., de Vries R.R., and Toes R.E. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 52 (2005) 2637-2644
58. Stone N.J., Bilek S., and Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol 96 (2005) 53E-59E
59. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
60. Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
61. Asia Pacific Cohort Studies Collaboration. The impact of cardiovascular risk factors on the age-related excess risk of coronary heart disease. Int J Epidemiol 35 (2006) 1025-1033
62. Jones D.W., and Hall J.E. Seventh report of the Joint National Committee on Prevention. Detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials. Hypertension 43 (2004) 1-3
63. American Diabetes Association. Diagnosis and classification of Diabetes Mellitus. Diab Care 27 (2004) S5-S10
64. Ginsberg H.N., and Stalenhoef A.F. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. J Cardiovasc Risk 10 (2003) 121-128
65. Roth S., Willcox N., Rzepka R., Mayer M.P., and Melchers I. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 116 (2007) 619-626
66. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 80 Suppl 2 (1998) S1-S29
67. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P., and CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
68. Liao Y., Kwon S., Shaughnessy S., Wallace P., Hutto A., Jenkins A.J., et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 27 (2004) 978-983
69. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
70. Klein S., Allison D.B., Heymsfield S.B., Kelley D.E., Leibel R.L., Nonas C., et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO. The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 85 (2007) 1197-1202
71. Wang Z., Rowley K., Wang Z., Piers L., and O'Dea K. Anthropometric indices and their relationship with diabetes, hypertension and dyslipidemia in Australian Aboriginal people and Torres Strait Islanders. Eur J Cardiovasc Prev Rehabil 14 (2007) 172-178
72. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., Wilson P., and CHD Risk Prediction Group. Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res 4 (2007) 32-38
73. Wendelhag I., Wiklund O., and Wikstrand J. Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in the common carotid artery. Arterioscler Thromb 12 (1992) 70-77
74. Salonen R., and Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 229 (1991) 225-231
75. Pignoli P., Tremoli E., Poli A., Oreste P., and Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74 (1986) 1399-1406
76. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25 (2007) 1105-1187 Erratum in: J Hypertens 2007;25:1749.
77. Lambert J., and Stehouwer C.D. Modulation of endothelium-dependent, flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 94 (1996) 2319-2320
78. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
79. Yeboah J., Burke G.L., Crouse J.R., and Herrington D.M. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: The Cardiovascular Health Study. Atherosclerosis (2007) [Epub ahead of print]
80. Accini J.L., Sotomayor A., Trujillo F., Barrera J.G., Bautista L., and López-Jaramillo P. Colombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV). Normal values and factors associated. Endothelium 2 (2001) 157-166
81. Tsimikas S., Brilakis E.S., Miller E.R., McConnell J.P., Lennon R.J., Kornman K.S., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353 (2005) 46-57
82. Le N.A., and Walter M.F. The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 9 (2007) 110-115
83. Georgiadis A.N., Papavasiliou E.C., Lourida E.S., Alamanos Y., Kostara C., Tselepis A.D., et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 8 (2006) R82
84. Edwards C.J., Syddall H., Goswami R., Goswami P., Dennison E.M., Arden N.K., et al. The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 93 (2007) 1263-1267
85. Turesson C., Jacobsson L.T., Sturfelt G., Matteson E.L., Mathsson L., and Rönnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66 (2007) 59-64
86. van Gaalen F.A. Testing for antibodies to cyclic citrullinated peptides and rheumatoid factor-what is best for early RA?. Nat Clin Pract Rheumatol 3 (2007) 488-489
87. Day C. Adipose tissue as an immunological organ: toll-like receptors C1q/TNFs and CTRPs. Trends Immunol 28 (2007) 393-399
88. del Rincón I.D., Williams K., Stern M.P., Freeman G.L., and Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44 (2001) 2737-2745
89. Ljung L., Olsson T., Engstrand S., Wållberg-Jonsson S., Söderberg S., and Rantapää-Dahlqvist S. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 8 (2006) R186
90. Del R., O'leary D.H., Freeman G.L., and Escalante A. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52 (2005) 3045-3053
91. Delgado-Vega A.M., and Anaya J.M. Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev 6 (2007) 402-408
92. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Lopez-Diaz M.J., Piñeiro A., Garcia-Porrua C., Miranda-Filloy J.A., et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57 (2007) 125-132
93. Gerli R., Sherer Y., Vaudo G., Schillaci G., Gilburd B., Giordano A., et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann NY Acad Sci 1051 (2005) 281-290
94. Chung C.P., Oeser A., Raggi P., Gebretsadik T., Shintani A.K., Sokka T., et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52 (2005) 3045-3053
95. Emery P., and Lugmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol 32 (1993) S3-S8
96. Koenig W., Sund M., Fröhlich M., Fischer H.G., Löwel H., Döring A., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
97. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
98. Del Rincón I., Williams K., Stern M.P., Freeman G.L., O'Leary D.H., and Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48 (2003) 1833-1840
99. Hwang S.J., Ballantyne C.M., Sharrett A.R., Smith L.C., Davis C.E., Gotto Jr. A.M., et al. Circulating adhesion molecules VCAM-1. ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 (1997) 4219-4225
100. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
101. Ridker P.M., Buring J.E., and Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 103 (2001) 491-495
102. Roivainen M., Viik-Kajander M., Palosuo T., Toivanen P., Leinonen M., Saikku P., et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (2000) 252-257
103. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Piñeiro A., Garcia-Porrua C., Testa A., and Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 1219-1223
104. Sattar N., McCarey D.W., Capell H., and McInnes I.B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108 (2003) 2957-2963
105. Abou-Raya A., and Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5 (2006) 331-337
106. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
107. Fischer M., Broeckel U., Holmer S., Baessler A., Hengstenberg C., Mayer B., et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111 (2005) 855-862
108. Nsengimana J., Samani N.J., Hall A.S., Balmforth A.J., Mangino M., Yuldasheva N., et al. Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolemia. Eur J Hum Genet 15 (2007) 313-319
109. Qiao J.H., Castellani L.W., Fishbein M.C., and Lusis A.J. Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb 13 (1993) 932-943
110. Szalai C., Füst G., Duba J., Kramer J., Romics L., Prohászka Z., et al. Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet 39 (2002) 46-51
111. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
112. Broeckel U., Hengstenberg C., Mayer B., Holmer S., Martin L.J., Comuzzie A.G., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 30 (2002) 210-214
113. Somers E.C., Thomas S.L., Smeeth L., and Hall A.J. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 17 (2006) 202-217
114. Eroglu G.E., and Kohler P.F. Familial systemic lupus erythematosus: the role of genetic and environmental factors. Ann Rheum Dis 61 (2002) 29-31
115. Björnådal L., Brandt L., Klareskog L., and Askling J. Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis. Ann Rheum Dis 65 (2006) 741-745
116. Pineda-Tamayo R., Arcila G., Restrepo P., and Anaya J.M. Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis. Biomedica 4 (2004) 366-374